AMICUS THERAPEUTICS, INC. — Director's Dealing 2017

Jun 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2017-06-15

Reporting Person: Barth Jay (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-15	Common Stock	M	1629	$8.79	Disposed	64184	Direct
2017-06-19	Common Stock	M	30000	$10.00	Acquired	94184	Direct
2017-06-19	Common Stock	S	30000	$10.00	Disposed	64184	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-03	Stock Options (right to buy)	$2.29	M	30000	Disposed	2024-03-03	Common Stock (30000)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2016.